Thermo Fisher Scientific
TMO
915 hedge funds and large institutions have $43.6B invested in Thermo Fisher Scientific in 2014 Q1 according to their latest regulatory filings, with 89 funds opening new positions, 321 increasing their positions, 373 reducing their positions, and 47 closing their positions.
164% more call options, than puts
Call options by funds: $472M | Put options by funds: $179M
89% more first-time investments, than exits
New positions opened: 89 | Existing positions closed: 47
5% more funds holding
Funds holding: 872 → 915 (+43)
9% more capital inflows, than outflows
Capital inflows: $4.57B | Capital outflows: $4.17B
2% less funds holding in top 10
Funds holding in top 10: 84 → 82 (-2)
7.09% less ownership
Funds ownership: 99.62% → 92.53% (-7.1%)
14% less repeat investments, than reductions
Existing positions increased: 321 | Existing positions reduced: 373
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Temasek Holdings
Singapore
|
+$627M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$377M |
| 3 |
Primecap Management
Pasadena,
California
|
+$367M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$261M |
| 5 |
Carmignac Gestion
Paris,
France
|
+$182M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$748M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$544M |
| 3 |
Sculptor Capital
New York
|
-$238M |
| 4 |
Barclays
London,
United Kingdom
|
-$154M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$146M |
TMO Hedge Fund Activity: Q1 2014 in Review
915 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q1 2014, worth a combined $43.6B — up 8.8% from $40.1B a quarter earlier.
Buyers outnumbered sellers: 89 funds opened new TMO positions and 47 closed out — a net gain of 42 holders — while 321 added to existing stakes and 373 trimmed.
The largest buyer was Temasek Holdings, opening a new position worth an estimated $627M. The largest seller was T. Rowe Price Associates, cutting an estimated $748M.
- 915 institutional investors held Thermo Fisher Scientific (TMO) as of Q1 2014, up from 872 in Q4 2013.
- Funds reported $43.6B of Thermo Fisher Scientific stock for Q1 2014, up 8.8% quarter-over-quarter.
- 89 funds opened new Thermo Fisher Scientific positions in Q1 2014 and 47 closed out, a net change of +42 holders.
- The largest Thermo Fisher Scientific buyer in Q1 2014 was Temasek Holdings, an estimated $627M added.
- The largest Thermo Fisher Scientific seller in Q1 2014 was T. Rowe Price Associates, an estimated $748M sold.
Based on aggregated 13F filings for Q1 2014.